Home =
regenerative medicine - search results
If you're not happy with the results, please do another search
A conversation with 3D Systems’ CTO David Leigh: “On the edge of what can or cannot be done”
You may spend over a decade in this industry, meeting the same people over and over, heard about others multiple times, yet when you see them in real life, and have your first conversation...
DOSSIER: The Tiny World of micro-additive manufacturing technologies
In the manufacturing industry in general, most innovations evolve around the ability to produce large 3D printed parts. However, with the growing demand for miniaturized devices in electronics, biotechnology, automotive, and aerospace, there is...
DOSSIER: The different roads that lead to effective 3D bioprinting
Whenever one reads an announcement that highlights 3D printed organs, one can easily be tempted to think that these organs can already be implanted within a human body but reality shows that there is...
3D Systems and United Therapeutics unveil 3D printed human lung scaffold
Ever since they have announced their partnership, 3D Systems and United Therapeutics have invested extra miles in the development of human lung scaffold. With the goal of creating a substantial supply of lungs ready...
A reconstructive procedure in the first-in-human Phase 1/2a clinical trial has been conducted using a 3D-bioprinted living tissue ear implant
3DBio Therapeutics (3DBio), a clinical-stage regenerative medicine company, and the Microtia-Congenital Ear Deformity Institute announced they have conducted a human ear reconstruction using the AuriNovo™ implant, an investigational, patient-matched, 3D-bioprinted living tissue ear implant. The...
BICO adds new light-based 3D bioprinting technology to its portfolio through the acquisition of Allegro 3D
BICO Bioprinting just strengthens its position on the bioprinting market by acquiring all the shares in San Diego-based Allegro 3D Inc. (“Allegro 3D”) for an up-front enterprise value of USD 6 million. The company already has...
A tripartite collaboration explores 3D Bioprinting to solve social issues related to food, health and environment
Food, health and environment are three verticals that share a common goal: the welfare of the population. While each of these verticals raises their own issues, it’s possible to address some of them with...
Trestle Biotherapeutics Licenses Innovations from Harvard University to Develop 3D Biofabricated Tissues to Treat Kidney Failure
Trestle Biotherapeutics, a private company based in San Diego, today announced that it has entered into a license agreement with Harvard University. Under the agreement, Trestle will commercialize a suite of stem cell- and...
3D Systems adds another 3D Bioprinting company to its portfolio
The merger will establish a new 20,000 sq. ft. facility within Houston’s East End Maker Hub
In a $45 million deal (€38 millions), Volumetric has signed an agreement to be acquired by AM company 3D...
3D Systems and CollPlant to enhance Breast Reconstruction Treatments with Bioprinted Solutions
Following the release of its 3D printer for solid-organ scaffolds as well as the acquisition of Allevi, 3D Systems continue to advance solutions in bioprinting through an agreement with CollPlant Biotechnologies, a regenerative and aesthetic...